Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × UNKNOWN × Everolimus × Clear all

Phase

Status

Sponsor Class

OTHER 44 OTHER_GOV 4 NIH 2 UNKNOWN 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Capecitabine 15 Paclitaxel 13 S 1 (combination) 9 apatinib 8 Oxaliplatin 8 Carboplatin 8 Cisplatin 7 pyrotinib 6 Epirubicin 6 Docetaxel 6 sintilimab 5 camrelizumab 5 anlotinib 5 Drug Therapy 5 130-nm albumin-bound paclitaxel 5 nimotuzumab 4 nedaplatin 4 Vinorelbine 4 Temozolomide 4 Radiotherapy 4 Irinotecan 4 Fulvestrant 4 Etoposide 4 Bevacizumab 4 toripalimab 3 titanium silicide 3 exemestane 3 Trastuzumab 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02313051 2014-12-09

MIRACLE

ChineseAMS

Phase 2 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡